Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

U.S. Sen. Bernie Sanders Urges Ohioans to Vote Yes on Issue 2

Ohio Taxpayers for Lower Drug Prices
Posted on: 06 Nov 17

In a final push to encourage Ohioans to vote Yes on Issue 2, U.S. Sen. Bernie Sanders, I-Vermont, is placing calls to more than 300,000 voters on Sunday and Monday.

This press release features multimedia. View the full release here:

United States Senator Bernie Sanders (I-VT), official Senate portrait (Photo: Business Wire)

Sanders encourages Ohioans to vote Yes on Issue 2:

“Hi, this is Senator Bernie Sanders. At a time when we pay by far the highest prices in the world for prescription drugs, the pharmaceutical industry is spending over $50 million in Ohio to defeat Issue 2, which will be on your ballot on November 7 th . Don’t let them get away with it. Issue 2 can lower drug prices for millions of Ohioans and for taxpayers. Please vote Yes on Issue 2. It’s time we stopped the greed of the drug companies. Thank you,” Sanders says in the call.

“U.S. Sen. Bernie Sanders has been a relentless fighter to lower drug prices in Ohio and across this nation. While the big drug companies spend more than $62 million to bombard the airwaves with false and lying ads, Sen. Sanders is speaking truth to power and letting Ohioans know they can stand up and win against the bully drug companies that put profits before patients,” said Dennis Willard, spokesman for the Yes on Issue 2 campaign.

Background on Ohio Ballot Issue 2

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on

Business Wire

Last updated on: 06/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.